The Experimental Drug Development Centre (EDDC) is Singapore’s national platform for drug discovery and development. We collaborate with public sector and industry partners to translate groundbreaking scientific discoveries into valuable biotherapeutic candidates.
Little Drug, Big Hope
ETC-159 is a small molecule Wnt-porcupine inhibitor developed in collaboration with Duke-NUS that has completed Phase 1B trials and showed promising outcomes for patients with platinum-resistant ovarian cancer (PROC). One such patient, Iren, has shared her journey and how she found renewed life through the ETC-159 clinical trial. Watch how a small but powerful drug is transforming lives and offering new hope to patients like Iren who face limited options.
Pipeline
EDDC aims to develop innovative therapeutics and companion diagnostics that have the potential to improve and save the lives of patients in Singapore and beyond. We want to advance the development of safe and effective therapies that address unmet medical needs.
We welcome partnerships with collaborators who share our vision, to jointly accelerate the development of our pipeline assets.
Newsroom
RDP Pharma AG and Experimental Drug Development Centre Launch Strategic Collaboration to Discover and Develop Monovalent Targeted Protein Degraders for Autoimmune Diseases
Recent News
Collaboration with Sprint Bioscience in Inflammatory Diseases
Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
Partner with Us
EDDC is equipped with comprehensive capabilities for advancing the discovery and development of small molecule or antibody-based drugs, as well as companion diagnostics.
As a publicly-funded researcher, you can benefit from our extensive expertise and capabilities to advance your drug discovery project in various ways.
Consultancy
Services